Jesper Zeuthen

Title: Jesper Zeuthen: Innovator in Medical Diagnostics

Introduction

Jesper Zeuthen is a notable inventor based in Virum, Denmark. He has made significant contributions to the field of medical diagnostics, particularly in the assessment of diabetes control and cancer detection. With a total of 4 patents to his name, Zeuthen's work has had a profound impact on healthcare.

Latest Patents

One of Jesper Zeuthen's latest patents involves the determination of glycated hemoglobin in blood. This invention utilizes a monoclonal antibody that specifically binds to HbA.sub.1c, allowing for the assessment of diabetes control without prior denaturation of blood samples. The analytical methods applicable to this invention include radioimmunoassay and enzyme-linked immunosorbent assay. Another significant patent is for modified .beta..sub.2-microglobulin, which is a diagnostic and prognostic marker for various disorders, including different types of cancer and diseases affecting the immune system. This patent also includes specific anti-m.beta..sub.2 m antibodies for the detection and quantification of the modified protein.

Career Highlights

Throughout his career, Jesper Zeuthen has worked with prominent companies such as Novo Industri A/S and Novo Nordisk A/S. His experience in these organizations has contributed to his expertise in medical diagnostics and innovation.

Collaborations

Jesper has collaborated with notable colleagues, including Lars Thim and Mogens H. Nissen. These partnerships have further enhanced his research and development efforts in the field.

Conclusion

Jesper Zeuthen's contributions to medical diagnostics through his innovative patents demonstrate his commitment to improving healthcare outcomes. His work continues to influence the assessment and treatment of various medical conditions.